• β-Amyloid (12-28) peptide

β-Amyloid (12-28) peptide

Not For Human Use, Lab Use Only.

Cat.#: 300277

Special Price 215.00 USD

Availability: 1-2 weeks
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    β-Amyloid (12-28) peptide
  • Documents
  • Sequence Shortening
    VHHQKLVFFAEDVGSNK
  • Sequence
    Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys
  • Length (aa)
    17
  • Peptide Purity (HPLC)
    96.4%
  • Molecular Formula
    C89H135N25O25
  • Molecular Weight
    1955.22
  • CAS No.
    107015-83-8
  • Source
    Synthetic
  • Form
    Powder
  • Description

    The β-Amyloid (12-28) peptide is a fragment of the full-length β-amyloid protein. This peptide encompasses residues 12 to 28 of the native sequence and contains a central hydrophobic region. Studies using techniques such as pulsed-field gradient NMR spectroscopy, Fourier transform infrared spectroscopy, and transmission electron microscopy have shown that the β-Amyloid (12-28) fragment undergoes a time-dependent aggregation process. The soluble fraction initially consists of monomeric species, which form oligomeric intermediates over time. These intermediates adopt an extended, non-spherical assembly. The aggregation ultimately results in the formation of fibrillar structures.

    These fibrillar aggregates exhibit a characteristic antiparallel β-sheet secondary structure, as confirmed by infrared spectroscopy. The aggregation kinetics of the β-Amyloid (12-28) fragment are noted to be slower compared to the full-length protein, but the resulting fibrillar morphology is similar. The peptide's behavior in solution, particularly the early oligomerization stages observed via NMR diffusion measurements, makes it a frequently studied model for investigating the fundamental biophysical processes of amyloid formation.

  • Storage Guidelines
    Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
  • References
    • Rabanal F, Tusell JM, Sastre L, Quintero MR, Cruz M, Grillo D, Pons M, Albericio F, Serratosa J, Giralt E. Structural, kinetic and cytotoxicity aspects of 12-28 beta-amyloid protein fragment: a reappraisal. J Pept Sci. 2002 Oct;8(10):578-88. doi: 10.1002/psc.418. PMID: 12450327.
  • About TFA salt

    Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.

    Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.

    Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.

    In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.

  • Molar Concentration Calculator

  • Dilution Calculator

  • Percent Concentration Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight

Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.

Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.

Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"